Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Jacobson

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
European Journal of Pharmacology|September 13, 1988
Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanateA N Schoffelmeer, K C Rice, A E Jacobson, et al.
European Journal of Pharmacology|May 13, 1986
Morphine tolerance increases mu-noncompetitive delta binding sitesR B Rothman, J A Danks, A E Jacobson, et al.
Neuroendocrinology|May 1, 1990
Anti-opioid receptor antibody recognition of a binding site on brain and leukocyte opioid receptorsD J Carr, B R DeCosta, C H Kim, et al.
Synapse (New York, N.Y.)|November 9, 2000
Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assayH Xu, A Hashimoto, K C Rice, et al.
European Journal of Pharmacology|August 29, 1989
Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypesR B Rothman, C P France, V Bykov, et al.
Journal of Medicinal Chemistry|June 1, 1986
Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivityT R Burke, A E Jacobson, K C Rice, et al.
FEBS Letters|July 17, 1989
Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptorsB R de Costa, W D Bowen, S B Hellewell, et al.
Neuroscience Letters|January 22, 1990
MK-801 ameliorates delayed amnesia, but potentiates acute amnesia induced by COT Nabeshima, S Yoshida, H Morinaka, et al.
Japanese Journal of Pharmacology|September 1, 1985
Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans)M D Aceto, L S Harris, J H Woods, et al.
Neuropeptides|April 1, 1985
Increased affinity of dimeric enkephalins is not dependent on receptor densityR A Lutz, T Costa, R A Cruciani, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
European Journal of Pharmacology|September 13, 1988
Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanateA N Schoffelmeer, K C Rice, A E Jacobson, et al.
European Journal of Pharmacology|May 13, 1986
Morphine tolerance increases mu-noncompetitive delta binding sitesR B Rothman, J A Danks, A E Jacobson, et al.
Neuroendocrinology|May 1, 1990
Anti-opioid receptor antibody recognition of a binding site on brain and leukocyte opioid receptorsD J Carr, B R DeCosta, C H Kim, et al.
Synapse (New York, N.Y.)|November 9, 2000
Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assayH Xu, A Hashimoto, K C Rice, et al.
European Journal of Pharmacology|August 29, 1989
Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypesR B Rothman, C P France, V Bykov, et al.
Journal of Medicinal Chemistry|June 1, 1986
Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivityT R Burke, A E Jacobson, K C Rice, et al.
FEBS Letters|July 17, 1989
Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptorsB R de Costa, W D Bowen, S B Hellewell, et al.
Neuroscience Letters|January 22, 1990
MK-801 ameliorates delayed amnesia, but potentiates acute amnesia induced by COT Nabeshima, S Yoshida, H Morinaka, et al.
Japanese Journal of Pharmacology|September 1, 1985
Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans)M D Aceto, L S Harris, J H Woods, et al.
Neuropeptides|April 1, 1985
Increased affinity of dimeric enkephalins is not dependent on receptor densityR A Lutz, T Costa, R A Cruciani, et al.
Pageof 17